Could CAR T-cell therapy (Chimeric Antigen Receptor) be expanded to treat multiple cancers? Early clinical trial observations being led by Dr. David Maloney, are quite remarkable. Dr. Maloney, an associate professor of medicine at the University of Washington, discusses his excitement over CAR T-cell therapy expansion. He helps us understand the wave of research efforts behind this adoptive T-cell therapy of using the patients own immune cells to fight back against the cancer, including blood cancers like chronic lymphocytic leukemia (CLL). Dr. Maloney provides insight on the process of collecting T cells, what the future holds for CAR therapy and its potential application to not only blood cancers, but perhaps solid tumors.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…